Health Care & Life Sciences » Pharmaceuticals | Eagle Pharmaceuticals Inc.

Eagle Pharmaceuticals Inc. | Mutual Funds

Mutual Funds that own Eagle Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Janus Triton Fund
1,117,381
7.52%
0
0.66%
06/30/2018
iShares Core S&P Small Cap ETF
462,787
3.11%
132
0.07%
09/06/2018
Janus Venture Fund
452,319
3.04%
0
0.85%
06/30/2018
SPDR S&P Biotech ETF
449,086
3.02%
1,155
0.53%
09/06/2018
HBM BioVentures Ltd.
380,631
2.56%
0
1.79%
12/31/2017
Vanguard Total Stock Market Index Fund
296,914
2%
0
0%
07/31/2018
JNL/Eagle Small Cap Equity Series
270,280
1.82%
-440
0.88%
03/31/2018
First Eagle Fund of America
267,608
1.8%
-333,897
0.94%
04/30/2018
PowerShares Dynamic Pharmaceuticals Portfolio
235,002
1.58%
1,306
2.44%
09/05/2018
Fidelity Select Biotechnology Portfolio
228,408
1.54%
0
0.17%
07/31/2018

About Eagle Pharmaceuticals

View Profile
Address
50 Tice Boulevard
Woodcliff Lake New Jersey 07677
United States
Employees -
Website http://www.eagleus.com
Updated 07/08/2019
Eagle Pharmaceuticals, Inc. engages in the provision of injectable products. Its products include argatroban; ryanodex; docetaxel injection, non-alcohol formulation; and bendeka. The company was founded by Scott L.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.